Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2014 December;56(4) > Panminerva Medica 2014 December;56(4):263-72

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

  MENOPAUSE IN 2014 

Panminerva Medica 2014 December;56(4):263-72

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Hormone replacement therapy: consensus and controversies

Shoupe D.

Division of Reproductive Endocrinology and Infertility, Keck School of Medicine, University of Southern California, Los Angeles, CA, US


PDF


While the use of menopausal hormone therapy [MHT] when initiated in women younger than 60 years is generally considered to have a good safety profile and to be associated with important treatment and prevention benefits, the length of therapy and the long-term risk benefit profile remains highly controversial.

top of page